Skip to main content
. 2019 Aug 19;25:6236–6243. doi: 10.12659/MSM.918454

Figure 1.

Figure 1

Downregulated miR-449b-5p in OS. (A) Relative levels of miR-449b-5p in OS tissues and paracancerous tissues. (B) Relative levels of miR-449b-5p in OS patients in stage II+III and stage I. (C) Relative levels of miR-449b-5p in OS patients in G1 and G2. (D) Kaplan-Meier curves showing overall survival of OS patients with high and low levels of miR-449b-5p.